Patricia Enel Selected Research

Raltegravir Potassium

1/2023

Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Enel Research Topics

Disease

2	Pain (Aches) 01/2021 - 02/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2014 - 01/2014
1	Weight Gain 01/2023
1	Frailty 01/2021
1	Neoplasms (Cancer) 01/2021
1	Infections 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Hepatitis 07/2018
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 07/2018
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2018
1	Hepatitis B 10/2014
1	Coinfection 10/2014

Drug/Important Bio-Agent (IBA)

1	Tenofovir (Viread)FDA Link 01/2023
1	Raltegravir Potassium FDA Link 01/2023
1	abacavir (Ziagen)FDA Link 01/2023
1	dolutegravirIBA 01/2023
1	IntegrasesIBA 01/2023
1	tenofovir alafenamideIBA 01/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	Reverse Transcriptase InhibitorsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2014
1	NucleosidesIBA 01/2014

Therapy/Procedure

1	Art Therapy 01/2021
1	Therapeutics 01/2020
1	Immunotherapy 07/2018
1	Activities of Daily Living (ADL) 02/2018